Dr. Aaron Gopal, MD

Dr. Gopal practices at INTEGRIS Health Miami Hospital - Mammography in Miami, Oklahoma.

Dr. Gopal's NPI, 1124401609, was assigned on July 2, 2015. Dr. Gopal graduated from Jefferson Medical College of Thomas Jefferson University in 2015. Dr. Gopal holds South Carolina license 90136.

Dr. Gopal's primary practice is INTEGRIS Health Miami Hospital - Mammography, at 200 2nd Ave SW, Miami, OK 74354. The practice phone is (918) 540-7551.

Dr. Gopal's primary practice is INTEGRIS Health Miami Hospital - Mammography in Miami, Oklahoma. Dr. Gopal is also affiliated with Spartanburg Medical Center. The medical group on file is Medical Group of the Carolinas - Family Medicine - Converse Heights. Dmand AI also links Dr. Gopal to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gopal practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gopal's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Gopal is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gopal's licenses on file in 2 states: South Carolina and Louisiana.

CMS data shows 2,462 Medicare services from Dr. Gopal across 29 procedure codes in 2024, for 927 Medicare patients. Medicare paid $152,156 for them.

CMS counts 927 Medicare patients who saw Dr. Gopal in 2024. The largest group is 75 to 84, with 377 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gopal's median patient age at 72, with 54% women.

In 2024, Dr. Gopal wrote 1,414 Medicare Part D claims for 324 patients. 78% of them were for generic drugs. CMS names the drug for 1,222 of them, across 24 drugs with 11 or more claims each, at $254,409 in total drug cost. In 2023, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Gopal for performance year 2024, reported through an alternative payment model (APM). Dr. Gopal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 63 procedures of coronary angioplasty and stenting by Dr. Gopal, more than 89% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Gopal, published from 2020 to 2023. Dr. Gopal's most frequent co-authors are Haitham M. Hreibe, MD, Mufaddal F. Kheda, MD and Norris Stanley Nahman, MD.

CMS Open Payments shows 599 general payments to Dr. Gopal from 54 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 64% of the total. Medtronic, Inc. paid the most, $9,893.

Dr. Gopal graduated from Jefferson Medical College of Thomas Jefferson University in 2015.